Consistent with the results of clinical big data analytics, our immunostaining revealed that the expressions level of phospho-Akt was significantly enhanced in recurrent tumor tissues compared with that in non-recurrent tumor tissues (Figure 4E). This evidence concerns the gene AKT1 and neoplasm.